Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonMS-DRG 838 Fee Schedule
Last Verified: October 2026
Healthcare providers use this code to document and receive reimbursement for visits that address high-level medical decision-making, often including multiple diagnoses or prescription management.
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT
| Key Fact | Detail |
|---|---|
| Service Type | Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms |
| Common Place of Service | 21 - Inpatient Hospital 22 - On Campus Outpatient Hospital |
| Complexity Level | High |
National average reimbursement for MS-DRG 838 by major payers:
$26,537.28
$25,824.48
$32,082.85
$32,557.72
Compare published rates across providers.
Choose a payer to see a sample of rates for MS-DRG 838.
MS-DRG 838
5 of 25 sample ratesHigher to lower in this preview
John Muir Health, John Muir Health Medical Center, Concord Campus
$98,097.95Published rateAlegent Health Bergan Mercy Health System, The Archbishop Bergan Mercy Hospital
Alegent Health - Bergan Mercy Health System
$41,699.78Published rateEmanate Health Foothill Presbyterian Hospital, Foothill Presbyterian Hospital
Emanate Health Foothill Presbyterian Hospital
$32,613.46Published rateMercy Hospital Joplin, Mercy Hospital Joplin
Mercy Hospital Joplin
$19,310.40Published rateWellmont Health System, Bristol Regional Medical Center Psychiatric Unit
Wellmont Health System
$3,783.00Published rate
Get a free rate benchmark for your specialty.
Choose your state and specialty to build a report from payer-published rates.
Use market rates to prepare your payer proposal.
Payer Contract Negotiation
Draft a fee schedule renegotiation letter.
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalMS-DRG 838 vs. Other Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms Codes
The MS-DRG 838 code is part of the Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms services . It represents a moderate-complexity encounter and is one of several codes that vary based on time spent, level of medical decision-making, and documentation requirements.
The MS-DRG 838 code involves more provider time and moderate medical decision-making, unlike lower-level codes that require less time and simpler assessments. It typically includes multiple diagnoses, medication management, or test interpretation, leading to higher reimbursement and more detailed documentation requirements.
| Code | Complexity | Description |
|---|---|---|
| 837-MS-DRG | High | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC |
| 838-MS-DRG | High | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT |
| 839-MS-DRG | High | CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including MS-DRG 838. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the 838 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.
Bring your top codes (like MS-DRG 838) and we'll show you how you compare in 15 minutes or less.